IP Library Assignment 024123/0177
Patent Assignment
Reel/Frame 024123/0177

Assignment of Assignor's Interest

Recorded: 2010-03-23 Pages: 3
Assignor
SHALWITZ, ROBERT
Executed: 2010-03-18
Assignee
AKEBIA THERAPEUTICS INC.
10300 ALLIANCE DR., SUITE 510, CINCINNATI, OHIO, 25242
Covered Property (1)
Compounds, Compositions, and Methods for Preventing Metastasis of Cancer Cells
Patent: 8,569,348 →
Application: 12/677,550 →
Publication: US 2012/0128625
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2010
From: SHALWITZ, ROBERT; PETERS, KEVIN G.
To: AKEBIA THERAPEUTICS
Reel/Frame 025415/0579 →
Assignment of Assignor's Interest Jul 8, 2011
From: SHALWITZ, ROBERT; PETERS, KEVIN G.
To: AKEBIA THERAPEUTICS INC.
Reel/Frame 026564/0646 →
Assignment of Assignor's Interest Feb 9, 2012
From: AKEBIA THERAPEUTICS, INC.
To: AERPIO THERAPEUTICS, INC.
Reel/Frame 027678/0824 →
Change of Name Jul 31, 2019
From: AERPIO THERAPEUTICS, INC.
To: AERPIO THERAPEUTICS LLC
Reel/Frame 049919/0768 →
Assignment of Assignor's Interest Apr 17, 2020
From: AERPIO THERAPEUTICS LLC
To: AERPIO PHARMACEUTICALS, INC.
Reel/Frame 052432/0789 →
Assignment of Assignor's Interest Sep 9, 2021
From: AERPIO PHARMACEUTICALS, INC.
To: EYEPOINT PHARMACEUTICALS, INC.
Reel/Frame 057448/0033 →